Log in or Sign up for Free to view tailored content for your specialty!
Headache News
'Disparities exist' in headache care, review shows
Numerous factors, including racism, socioeconomic and insurance status, and geographical disparities, contributed to “inequities” in treating headache disorders, according to the authors of a literature review published in Neurology.
Vyepti demonstrates efficacy in patients with migraine
Among patients who experienced a moderate to severe migraine attack, IV treatment with Vyepti shortened time to headache and symptom resolution compared with placebo, according to results from a randomized clinical trial.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Neurologists navigate 'challenging' delivery of care during COVID-19
A survey of community neurologists demonstrated four primary themes associated with the impact of the COVID-19 pandemic in this group, specifically highlighting “the unusual environment” in which these providers practice.
Acute treatments alleviate pain, functional difficulties caused by migraine
Certain acute treatments for episodic migraines improved pain and function, according to a systemic review and meta-analysis study published in JAMA.
Q&A: Migraine causes 'tremendous and complex burden' for patients
Rebecca Erwin Wells, MD, MPH, received the Early Career Award at the American Headache Society Annual Scientific Meeting in recognition of her paper that examined the impact of migraine on “multiple domains of life.”
Novel nerve stimulation device provides migraine pain relief
Cefaly Technology’s nerve stimulation device, when compared with sham stimulation, was more effective in delivering pain relief and freedom from most bothersome migraine symptom, phase 3 trial data show.
Q&A: Atogepant decreases monthly migraine days in phase 3 trial
Atogepant demonstrated “clinically meaningful and statistically significant” improvement for the primary endpoint of decreasing the mean number of monthly migraine days compared with placebo, according to results of a phase 3 trial.
Nitrates top list of medications that trigger headaches, analysis shows
Nitrates were the most frequent cause of medication-induced headaches, according to an analysis of more than 2.6 million records in the FDA’s Adverse Event Reporting System.
Nurtec ODC allows for new 'adaptive' approach to individual migraine treatment needs
Oral Nurtec ODT 75 mg taken every other day effectively prevented migraines, according to results of a randomized, double-blind, placebo-controlled trial presented at the American Headache Society Virtual Annual Scientific Meeting.
Headache, mood disorders increase among pediatric patients during COVID-19 pandemic
Pediatric patients with headache experienced increased headache frequency, poorer anxiety and mood, less physical activity and more screen time during the COVID-19 pandemic, despite reported improvements in hydration, sleep and diet.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read